Sympathetic Mapping/ Ablation of Renal Nerves Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 220 participants.
Also called NCT02761811
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 220 participants
- Sponsor
- Registry
-
NCT02761811
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02761811. Randomized; single masking; primary purpose treatment. Start 2016-06-30 (registry gives no type); primary completion 2022-08-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sympathetic Mapping/ Ablation of Renal Nerves Trial
- Acronym
- SMART
- Condition
- Hypertension
- Intervention (Device)
- SyMapCath I™ catheter and SYMPIONEER S1™ Stimulator/Generator
- Lead sponsor
- SyMap Medical (Suzhou), Ltd.
- Collaborator
- Tigermed Consulting Co., Ltd
Record details
- Record id
cardio:ct-nct02761811- Content hash
10a10ff99d1573c34870e342986725acdcfbe3f3ba557a26a212a6e13fa68cc8